**Study Summary:** This study is testing a medicine called **rocatinlimab** to see if it helps reduce asthma attacks in people with moderate-to-severe asthma. Asthma is a condition where your airways swell, making it hard to breathe. Rocatinlimab is being studied to see if it can make asthma symptoms better. **Eligibility:** To participate, you must be 18 to 75 years old and have had asthma for at least a year. You should be on medium to high doses of inhaled corticosteroids (ICS), which are medicines that help reduce inflammation in the airways. You also need to have had at least one asthma attack in the past year. However, if you've needed emergency treatment for asthma recently, or have other lung diseases, you might not be able to join. **Key Points:** - **Study Duration:** Participants will be involved for several months, undergoing various visits. - **Treatment & Visits:** You'll receive the study medication and need to visit the clinic for check-ups. - **Risks:** As with any study, there might be risks, so it's important to discuss them with the study team. If you're interested, ensure you meet the criteria and discuss with your doctor if this study is suitable for you.